Sursa: Banca Naţională a României
View more
View less

Folow us

Modifică dimensiunea fontului:

The National Coordinating Committee for Vaccination Activities against COVID-19 (CNCAV) informs that, in the last 24 hours, 85,604 doses of vaccine have been administered, of which 70,093 - Pfizer, 6,972 - Moderna and 8,494 - AstraZeneca and 45 - Johnson&Johnson, according to the data provided by the Institute National Public Health Registry through the application of the National Electronic Register of Vaccinations.

According to a CNCAV release, sent to AGERPRES on Tuesday, 32,629 people received the first jab, and 52,975 people got the second shot.

Since the beginning of the vaccination campaign, on December 27, 2020, 5,493,913 doses have been administered to a number of 3,411,328 people, of whom 1,328,743 received one dose and 2,082,585 the second dose as well.

In the last 24 hours, 41 adverse reactions were reported - 6 local and 35 whole-body.

At the same time, since the beginning of the vaccination campaign, there have been 14,319 adverse reactions to Pfizer, Moderna and AstraZeneca vaccines - 1,535 local and 12,784 whole-body.

CNCAV mentions that 145 side effects are being investigated. AGERPRES (RO - author: Petronius Craiu, editor: Claudia Stanescu; EN - author: Bogdan Gabaroi, editor: Adina Panaitescu)

The content of the website has the exclusive purpose of public informing.
All the information published on this website by AGERPRES is protected by relevant legal dispositions.
It is forbidden to copy, reproduce, recompile, decompile, distribute, publish, display, modify, create derived components or products or full services, as well as any exploitation of the site's content.
Details in the section Terms of Use. If you are interested in picking up AGERPRES news items, please contact the Marketing Department –

The use of the Comments section entails your obligation to respect the AGERPRES terms and conditions in regards to the publishing of comments on the

Sursa: Administrația Națională de Meteorologie


Dacă ai cont gratuit te loghezi cu adresa de email. Pentru a crea un cont gratuit accesează secțiunea “Crează cont”.

Dacă ai cont plătit te loghezi cu username. Pentru a vă crea un cont plătit vă rugăm să contactați:

Dacă nu puteți vizualiza această știre, contactați echipa AGERPRES pentru a vă abona la fluxurile de știri.